# GMP Manufacturing Framework (Research Readiness)

This framework defines the minimum release and traceability artifacts required before mRNA construct handoff to manufacturing partners.

## Scope

- Research and pre-clinical manufacturing readiness only.
- Not a replacement for jurisdiction-specific GMP regulations.
- Intended to produce auditable, machine-readable release artifacts.

## Required Controls

- Identity: Sequence identity and traceability hash.
- Purity: Placeholder in current implementation (lab-measured value required).
- Potency: Placeholder in current implementation (bioassay required).
- Sterility: Required as pass/fail gate before release.
- Endotoxin: Required as pass/fail gate before release.
- GC Window: Construct GC must remain between 40% and 60%.

## Generated Artifact

The patient pipeline now emits a `gmp_release_record` block in JSON output with:

- `batch_id`
- `sample_id`
- `created_utc`
- `gc_content`
- `gc_window_pass`
- `mrna_length`
- `sterility_check`
- `endotoxin_check`
- `identity_check`
- `release_status`
- `qa_signoff_required`
- `traceability_hash`

## Operational Workflow

1. Run patient pipeline and generate JSON report.
2. Validate `gmp_release_record.gc_window_pass` is true.
3. Populate sterility/endotoxin/potency/purity from QC lab systems.
4. Require QA signoff for release.
5. Archive batch record with immutable storage policy.

## Next Steps Toward Full GMP

1. Add electronic batch record signatures.
2. Integrate LIMS/QMS IDs in the JSON record.
3. Add audit-trail events for each QC step.
4. Add validated acceptance criteria versioning.
